Clarion, Aaron G.
HRN: 24-76-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/26/2024
05/03/2024
IV
30mg
Q 12
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes